ArticleRadiology2020
The QIBA Profile for FDG PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy.
Abstract read
In one paragraph
Article in Radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
52 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Radiomics-based approaches outperform visual analysis for differentiating lipoma from atypical lipomatous tumors: a review.Skeletal radiology · 2023Pooled it
- Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial Subanalysis.International journal of molecular sciences · 2026Trial
- Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024Trial
- Optimization of PET acquisition time for thoracic lesions inEuropean radiology experimental · 2026Article
- Reply to Çınar, A. The Potential Role of Organ-to-Liver Ratios in Immune-Related FDG PET Imaging. Comment on "Panikar et al. Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial Subanalysis.International journal of molecular sciences · 2026Article
- Myocardial flow reserve estimation from standardized uptake values ofAnnals of nuclear medicine · 2026Article
- Advanced herbal self-assembled nanoplatforms: targeted, stimuli-responsive, and precision therapeutics for human diseases.Journal of nanobiotechnology · 2026Review
- Review
- The prognostic value of baseline EARL standardized FDG PET indices in pediatric and adolescent high-grade osteosarcoma.European radiology · 2025Article
- Pretreatment PET dissemination features as biomarkers for survival outcomes in melanoma patients treated with immune-checkpoint inhibitors.Scientific reports · 2025Article
- PET/CT acquisition and processing protocols in the Netherlands.EJNMMI physics · 2025Article
- A compositeBreast (Edinburgh, Scotland) · 2025Article
- Usefulness of a new anthropomorphic phantom simulating the chest and abdomen regions in PET tests.Annals of nuclear medicine · 2025Article
- Quantification in respiratory-gated PET acquisition: can data-driven methods replace device-based systems?-a comparative and retrospective study.EJNMMI research · 2025Article
- Comparative evaluation of Ordered Subset Expectation Maximization and Bayesian Penalized Likelihood algorithms for PET/CT image reconstruction in various malignancies usingFrontiers in oncology · 2025Article
- Robust radiomics: a review of guidelines for radiomics in medical imaging.Frontiers in radiology · 2025Review
- [Asia Oceania journal of nuclear medicine & biology · 2025Article
- Quantitative Assessments of Tumor Activity in a General Oncologic PET/CT Population: Which Metric Minimizes Tracer Uptake Time Dependence?Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024Article
- The impact of introducing deep learning based [EJNMMI research · 2024Article
- Evaluations of an Early Change in Tumor Pathophysiology in Response to Radiotherapy with Oxygen Enhanced Electron Paramagnetic Resonance Imaging (OE EPRI).Molecular imaging and biology · 2024Article
Corrections and comments
- Commented on by
Authors and funding
10 authors.
Paul E KinahanFrom the Department of Radiology, University of Washington, 1959 NE Pacific St, RR215, Box 357115, Seattle, WA 98195-7117 (P.E.K.); Perlman Advisory Group, LLC, Hillsdale, NY (E.S.P.); Department of Radiology, University of Iowa, Iowa City, Iowa (J.J.S.); Department of Radiology, University of Texas Southwestern, Dallas, Tex (R.S.); GE Healthcare, Waukesha, Wis (S.D.W.); Department of Radiology, Duke University Medical Center, Durham, NC (T.G.T.); The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Md (M.A.L.); Department of Radiology and Nuclear Medicine, Amsterdam, the Netherlands (R.B.); Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio (N.A.O.); and Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (R.L.W.).ORCID 0000-0001-6461-3306
Eric S PerlmanFrom the Department of Radiology, University of Washington, 1959 NE Pacific St, RR215, Box 357115, Seattle, WA 98195-7117 (P.E.K.); Perlman Advisory Group, LLC, Hillsdale, NY (E.S.P.); Department of Radiology, University of Iowa, Iowa City, Iowa (J.J.S.); Department of Radiology, University of Texas Southwestern, Dallas, Tex (R.S.); GE Healthcare, Waukesha, Wis (S.D.W.); Department of Radiology, Duke University Medical Center, Durham, NC (T.G.T.); The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Md (M.A.L.); Department of Radiology and Nuclear Medicine, Amsterdam, the Netherlands (R.B.); Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio (N.A.O.); and Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (R.L.W.).
John J SunderlandFrom the Department of Radiology, University of Washington, 1959 NE Pacific St, RR215, Box 357115, Seattle, WA 98195-7117 (P.E.K.); Perlman Advisory Group, LLC, Hillsdale, NY (E.S.P.); Department of Radiology, University of Iowa, Iowa City, Iowa (J.J.S.); Department of Radiology, University of Texas Southwestern, Dallas, Tex (R.S.); GE Healthcare, Waukesha, Wis (S.D.W.); Department of Radiology, Duke University Medical Center, Durham, NC (T.G.T.); The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Md (M.A.L.); Department of Radiology and Nuclear Medicine, Amsterdam, the Netherlands (R.B.); Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio (N.A.O.); and Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (R.L.W.).
Rathan SubramaniamFrom the Department of Radiology, University of Washington, 1959 NE Pacific St, RR215, Box 357115, Seattle, WA 98195-7117 (P.E.K.); Perlman Advisory Group, LLC, Hillsdale, NY (E.S.P.); Department of Radiology, University of Iowa, Iowa City, Iowa (J.J.S.); Department of Radiology, University of Texas Southwestern, Dallas, Tex (R.S.); GE Healthcare, Waukesha, Wis (S.D.W.); Department of Radiology, Duke University Medical Center, Durham, NC (T.G.T.); The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Md (M.A.L.); Department of Radiology and Nuclear Medicine, Amsterdam, the Netherlands (R.B.); Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio (N.A.O.); and Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (R.L.W.).ORCID 0000-0001-9417-0649
Scott D WollenweberFrom the Department of Radiology, University of Washington, 1959 NE Pacific St, RR215, Box 357115, Seattle, WA 98195-7117 (P.E.K.); Perlman Advisory Group, LLC, Hillsdale, NY (E.S.P.); Department of Radiology, University of Iowa, Iowa City, Iowa (J.J.S.); Department of Radiology, University of Texas Southwestern, Dallas, Tex (R.S.); GE Healthcare, Waukesha, Wis (S.D.W.); Department of Radiology, Duke University Medical Center, Durham, NC (T.G.T.); The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Md (M.A.L.); Department of Radiology and Nuclear Medicine, Amsterdam, the Netherlands (R.B.); Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio (N.A.O.); and Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (R.L.W.).ORCID 0000-0001-6105-6831
Timothy G TurkingtonFrom the Department of Radiology, University of Washington, 1959 NE Pacific St, RR215, Box 357115, Seattle, WA 98195-7117 (P.E.K.); Perlman Advisory Group, LLC, Hillsdale, NY (E.S.P.); Department of Radiology, University of Iowa, Iowa City, Iowa (J.J.S.); Department of Radiology, University of Texas Southwestern, Dallas, Tex (R.S.); GE Healthcare, Waukesha, Wis (S.D.W.); Department of Radiology, Duke University Medical Center, Durham, NC (T.G.T.); The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Md (M.A.L.); Department of Radiology and Nuclear Medicine, Amsterdam, the Netherlands (R.B.); Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio (N.A.O.); and Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (R.L.W.).ORCID 0000-0003-0091-4681
Martin A LodgeFrom the Department of Radiology, University of Washington, 1959 NE Pacific St, RR215, Box 357115, Seattle, WA 98195-7117 (P.E.K.); Perlman Advisory Group, LLC, Hillsdale, NY (E.S.P.); Department of Radiology, University of Iowa, Iowa City, Iowa (J.J.S.); Department of Radiology, University of Texas Southwestern, Dallas, Tex (R.S.); GE Healthcare, Waukesha, Wis (S.D.W.); Department of Radiology, Duke University Medical Center, Durham, NC (T.G.T.); The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Md (M.A.L.); Department of Radiology and Nuclear Medicine, Amsterdam, the Netherlands (R.B.); Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio (N.A.O.); and Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (R.L.W.).ORCID 0000-0003-0922-6519
Ronald BoellaardFrom the Department of Radiology, University of Washington, 1959 NE Pacific St, RR215, Box 357115, Seattle, WA 98195-7117 (P.E.K.); Perlman Advisory Group, LLC, Hillsdale, NY (E.S.P.); Department of Radiology, University of Iowa, Iowa City, Iowa (J.J.S.); Department of Radiology, University of Texas Southwestern, Dallas, Tex (R.S.); GE Healthcare, Waukesha, Wis (S.D.W.); Department of Radiology, Duke University Medical Center, Durham, NC (T.G.T.); The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Md (M.A.L.); Department of Radiology and Nuclear Medicine, Amsterdam, the Netherlands (R.B.); Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio (N.A.O.); and Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (R.L.W.).ORCID 0000-0002-0313-5686
Nancy A ObuchowskiFrom the Department of Radiology, University of Washington, 1959 NE Pacific St, RR215, Box 357115, Seattle, WA 98195-7117 (P.E.K.); Perlman Advisory Group, LLC, Hillsdale, NY (E.S.P.); Department of Radiology, University of Iowa, Iowa City, Iowa (J.J.S.); Department of Radiology, University of Texas Southwestern, Dallas, Tex (R.S.); GE Healthcare, Waukesha, Wis (S.D.W.); Department of Radiology, Duke University Medical Center, Durham, NC (T.G.T.); The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Md (M.A.L.); Department of Radiology and Nuclear Medicine, Amsterdam, the Netherlands (R.B.); Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio (N.A.O.); and Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (R.L.W.).ORCID 0000-0003-1891-7477
Richard L WahlFrom the Department of Radiology, University of Washington, 1959 NE Pacific St, RR215, Box 357115, Seattle, WA 98195-7117 (P.E.K.); Perlman Advisory Group, LLC, Hillsdale, NY (E.S.P.); Department of Radiology, University of Iowa, Iowa City, Iowa (J.J.S.); Department of Radiology, University of Texas Southwestern, Dallas, Tex (R.S.); GE Healthcare, Waukesha, Wis (S.D.W.); Department of Radiology, Duke University Medical Center, Durham, NC (T.G.T.); The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Md (M.A.L.); Department of Radiology and Nuclear Medicine, Amsterdam, the Netherlands (R.B.); Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio (N.A.O.); and Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (R.L.W.).ORCID 0000-0002-7306-2590
Funding
Advanced PET/CT Imaging for Improving Clinical TrialsU01CA148131 · NCI · UNIVERSITY OF WASHINGTON · PI KINAHAN, PAUL E., LINDEN, HANNAH M · 2010 to 2019
$6.0MECOG-ACRIN-Based QIN Resource for Advancing Quantitative Cancer Imaging in Clinical TrialsU01CA190254 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI SCHNALL, MITCHELL D. · 2015 to 2019
$3.2MHarmonized PET Reconstructions for Cancer Clinical TrialsR01CA169072 · NCI · UNIVERSITY OF IOWA · PI KARP, JOEL S, KINAHAN, PAUL E. · 2012 to 2016
$2.4MNCI NIH HHS R01 CA169072NCI NIH HHS U01 CA148131NCI NIH HHS U01 CA190254NHLBI NIH HHS HHSN268201500021CNIBIB NIH HHS HHSN268201000050CNIBIB NIH HHS HHSN268201300071C
Abstract
The Quantitative Imaging Biomarkers Alliance (QIBA) Profile for fluorodeoxyglucose (FDG) PET/CT imaging was created by QIBA to both characterize and reduce the variability of standardized uptake values (SUVs). The Profile provides two complementary claims on the precision of SUV measurements. First, tumor glycolytic activity as reflected by the maximum SUV (SUV
Indexed as
Biomarkers, TumorFluorodeoxyglucose F18HumansImage Interpretation, Computer-AssistedNeoplasmsNeoplasm StagingPositron Emission Tomography Computed TomographyTreatment OutcomeBiomarkers, TumorFluorodeoxyglucose F18
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.